Advertisement

Brain Imaging and Behavior

, Volume 13, Issue 5, pp 1255–1264 | Cite as

Cortical thickness and subcortical volumes alterations in euthymic bipolar I patients treated with different mood stabilizers

  • Linling Li
  • Erni Ji
  • Xue Han
  • Fei Tang
  • Yuanhan Bai
  • Daihui Peng
  • Yiru Fang
  • Shengli Zhang
  • Zhiguo ZhangEmail author
  • Haichen YangEmail author
Original Research

Abstract

Reported structural abnormalities of patients with bipolar disorder (BD) are inconsistent and the use of psychotropic medication is one of the sources of heterogeneity. A fairly small number of morphometric studies have involved comparison of BD on different mood stabilizers. Here in this study, we aimed to investigate the cortical thickness and subcortical volumes in euthymic BD patients on lithium and valproate and healthy controls (HC), and to elucidate the relationship between the use of medication and brain structure variations. We acquired structural magnetic resonance imaging data from 35 BD patients (19/valproate;16/lithium) and 30 HC subjects. Cortical thickness was compared in multiple locations across the continuous cortical surface, and subcortical volumes were compared on a structure-by-structure basis. Group analyses revealed widespread thinning of the prefrontal cortex in BD. Compared with BD on valproate, BD on lithium showed significant increased cortical thickness of the left rostral middle frontal cortex and right superior frontal cortex, while cortical thickness was not significantly different between BD on lithium and HC in the bilateral rostral middle frontal cortex. Moreover, no significant difference was observed in subcortical volume. Limitations of this study comprise the possible effect of other psychotropic drugs, small sample size and the cross-sectional design. Therefore, the results suggest medication-related neurobiological difference between BD patients on different mood stabilizers, but no casual role can be proposed. Our findings provided new evidence about the effects of psychotropic medication upon neuroanatomy in BD, and could help to explain the inconsistency of existing studies as well as contribute to the extraction of reliable neuroimaging biomarkers in BD.

Keywords

Bipolar disorder Euthymia Mood stabilizers MRI Prefrontal cortex 

Notes

Funding

This work was supported by the Science and Technology Bureau of Shenzhen city (grant number JCYJ20150402093137765 and 20170814183413357), the Sanming Project of Medicine in Shenzhen (grant number SZSM201612006), the National Natural Science Foundation of China (grant number 81871443), and the Shenzhen Peacock Plan (grant number KQTD2016053112051497).

Compliance with ethical standards

Conflict of interest

Linling Li, Erni Ji, Xue Han, Fei Tang, Yuanhan Bai, Daihui Peng, Yiru Fang, Shengli Zhang, Zhiguo Zhang and Haichen Yang declare that they have no conflicts of interest.

Ethical approval

All procedures performed in this study were approved by the Human Research Ethics Committee of the Shenzhen Mental Health Centre, and were conducted in accordance with the 1964 Helsinki declaration and its later amendments.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Supplementary material

11682_2018_9950_MOESM1_ESM.docx (22 kb)
ESM 1 (DOCX 22 kb)

References

  1. Ahearn, E. P., Chen, P., Hertzberg, M., Cornette, M., Suvalsky, L., Cooleyolson, D., et al. (2013). Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics. Journal of Affective Disorders, 145(1), 77–82.Google Scholar
  2. Arnone, D., Cavanagh, J., Gerber, D., Lawrie, S. M., Ebmeier, K. P., & Mcintosh, A. M. (2009). Magnetic resonance imaging studies in bipolar disorder and schizophrenia: Meta-analysis. British Journal of Psychiatry, 195(3), 194–201.Google Scholar
  3. Atmaca, M., Ozdemir, H., Cetinkaya, S., Parmaksiz, S., Belli, H., Poyraz, A. K., et al. (2007). Cingulate gyrus volumetry in drug free bipolar patients and patients treated with valproate or valproate and quetiapine. Journal of Psychiatric Research, 41(10), 821–827.Google Scholar
  4. Baloch, H. A., Hatch, J. P., Olvera, R. L., Nicoletti, M., Caetano, S. C., Zunta-Soares, G. B., & Soares, J. C. (2010). Morphology of the subgenual prefrontal cortex in pediatric bipolar disorder. Journal of Psychiatric Research, 44(15), 1106–1110.Google Scholar
  5. Bearden, C. E., Thompson, P. M., Dalwani, M., Hayashi, K. M., Lee, A. D., Nicoletti, M., Trakhtenbroit, M., Glahn, D. C., Brambilla, P., Sassi, R. B., Mallinger, A. G., Frank, E., Kupfer, D. J., & Soares, J. C. (2007). Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biological Psychiatry, 62(1), 7–16.Google Scholar
  6. Behan, Á. T., & Cotter, D. R. (2006). Neuropathology of mood disorders. Psychiatry, 5(5), 180–182.Google Scholar
  7. Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B (Statistical Methodology), 57(1), 289–300.Google Scholar
  8. Caseras, X., Murphy, K., Lawrence, N. S., Fuentes-Claramonte, P., Watts, J., Jones, D. K., & Phillips, M. L. (2015). Emotion regulation deficits in euthymic bipolar I versus bipolar II disorder: A functional and diffusion-tensor imaging study. Bipolar Disorders, 17(5), 461–470.Google Scholar
  9. Chang, K., Karchemskiy, A., Barneagoraly, N., Garrett, A., Simeonova, D. I., & Reiss, A. (2005). Reduced amygdalar gray matter volume in familial pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44(6), 565–573.Google Scholar
  10. Chang, K., Karchemskiy, A., Kelley, R., Howe, M., Garrett, A., Adleman, N., & Reiss, A. (2009). Effect of divalproex on brain morphometry, chemistry, and function in youth at high-risk for bipolar disorder: A pilot study. Journal of Child and Adolescent Psychopharmacology, 19(1), 51–59.Google Scholar
  11. Chen, G., Zeng, W. Z., Yuan, P. X., Huang, L. D., Jiang, Y. M., Zhao, Z. H., & Manji, H. K. (1999). The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. Journal of Neurochemistry, 72(2), 879–882.Google Scholar
  12. Chen, C. H., Suckling, J., Lennox, B. R., Ooi, C., & Bullmore, E. T. (2011). A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disorders, 13(1), 1–15.Google Scholar
  13. Chiu, C. T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013). Therapeutic potential of mood stabilizers lithium and valproic acid: Beyond bipolar disorder. Pharmacological Reviews, 65(1), 105–142.Google Scholar
  14. Dale, A. M., Fischl, B., & Sereno, M. I. (1999). Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage, 9(2), 179–194.Google Scholar
  15. Elvsåshagen, T., Westlye, L. T., Bøen, E., Hol, P. K., Andreassen, O. A., Boye, B., & Malt, U. F. (2013). Bipolar II disorder is associated with thinning of prefrontal and temporal cortices involved in affect regulation. Bipolar Disorders, 15(8), 855–864.Google Scholar
  16. First, M. B., Spitzer, R. L., Miriam, G., & Williams, J. B. W. (1997). User's guide for the structured clinical interview for DSM-IV axis I disorders SCID-I: clinician version: American Psychiatric Publishing incorporated.Google Scholar
  17. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2002). Structured clinical interview for DSM-IV-TR axis I disorders, research version, non-patient edition. (SCID-I/NP). New York state psychiatric institute: New York: Biometrics research.Google Scholar
  18. Fischl, B., & Dale, A. M. (2000). Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proceedings of the National Academy of Sciences, 97(20), 11050–11055.Google Scholar
  19. Fischl, B., Sereno, M. I., & Dale, A. M. (1999). Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage, 9(2), 195–207.Google Scholar
  20. Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., Montillo, A., Makris, N., Rosen, B., & Dale, A. M. (2002). Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron, 33(3), 341–355.Google Scholar
  21. Fischl, B., van der Kouwe, A., Destrieux, C., Halgren, E., Segonne, F., Salat, D. H., et al. (2004). Automatically parcellating the human cerebral cortex. Cerebral Cortex, 14(1), 11–22.Google Scholar
  22. Foland, L. C., Altshuler, L. L., Sugar, C. A., Lee, A. D., Leow, A. D., Townsend, J., Narr, K. L., Asuncion, D. M., Toga, A. W., & Thompson, P. M. (2008). Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium. Neuroreport, 19(2), 221–224.Google Scholar
  23. Foland-Ross, L. C., Thompson, P. M., Sugar, C. A., Madsen, S. K., Shen, J. K., Penfold, C., Ahlf, K., Rasser, P. E., Fischer, J., Yang, Y., Townsend, J., Bookheimer, S. Y., & Altshuler, L. L. (2011). Investigation of cortical thickness abnormalities in lithium-free adults with bipolar I disorder using cortical pattern matching. American Journal of Psychiatry, 168(5), 530–539.Google Scholar
  24. Foland-Ross, L. C., Thompson, P. M., Sugar, C. A., Narr, K. L., Penfold, C., Vasquez, R. E., Townsend, J., Fischer, J., Saharan, P., Bearden, C. E., & Altshuler, L. L. (2013). Three-dimensional mapping of hippocampal and amygdalar structure in euthymic adults with bipolar disorder not treated with lithium. Psychiatry Research, 211(3), 195–201.Google Scholar
  25. Garrett, A., & Chang, K. (2008). The role of the amygdala in bipolar disorder development. Development and Psychopathology, 20(4), 1285–1296.Google Scholar
  26. Hafeman, D. M., Chang, K. D., Garrett, A. S., Sanders, E. M., & Phillips, M. L. (2012). Effects of medication on neuroimaging findings in bipolar disorder: An updated review. Bipolar Disorders, 14(4), 375–410.Google Scholar
  27. Hajek, T., Cullis, J., Novak, T., Kopecek, M., Höschl, C., Blagdon, R., O’Donovan, C., Bauer, M., Young, L. T., MacQueen, G., & Alda, M. (2012a). Hippocampal volumes in bipolar disorders: Opposing effects of illness burden and lithium treatment. Bipolar Disorders, 14(3), 261–270.Google Scholar
  28. Hajek, T., Kopecek, M., Höschl, C., & Alda, M. (2012b). Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: A meta-analysis. Journal of Psychiatry & Neuroscience, 37(5), 333–343.Google Scholar
  29. Hamilton, M. (1967). Development of a rating scale for primary depressive illness. The British Journal of Social and Clinical Psychology, 6(4), 278–296.Google Scholar
  30. Hanford, L. C., Nazarov, A., Hall, G. B., & Sassi, R. B. (2016). Cortical thickness in bipolar disorder: A systematic review. Bipolar Disorders, 18(1), 4–18.Google Scholar
  31. Hartberg, C. B., JøRgensen, K. N., Haukvik, U. K., Westlye, L. T., Melle, I., Andreassen, O. A., et al. (2015). Lithium treatment and hippocampal subfields and amygdala volumes in bipolar disorder. Bipolar Disorders, 17(5), 496–506.Google Scholar
  32. Hibar, D. P., Westlye, L. T., van Erp, T. G. M., Rasmussen, J., Leonardo, C. D., Faskowitz, J., et al. (2016). Subcortical volumetric abnormalities in bipolar disorder. Molecular Psychiatry, 21(12), 1710–1716.Google Scholar
  33. Hibar, D. P., Westlye, L. T., Doan, N. T., Jahanshad, N., Cheung, J. W., Ching, C. R. K., Versace, A., Bilderbeck, A. C., Uhlmann, A., Mwangi, B., Krämer, B., Overs, B., Hartberg, C. B., Abé, C., Dima, D., Grotegerd, D., Sprooten, E., Bøen, E., Jimenez, E., Howells, F. M., Delvecchio, G., Temmingh, H., Starke, J., Almeida, J. R. C., Goikolea, J. M., Houenou, J., Beard, L. M., Rauer, L., Abramovic, L., Bonnin, M., Ponteduro, M. F., Keil, M., Rive, M. M., Yao, N., Yalin, N., Najt, P., Rosa, P. G., Redlich, R., Trost, S., Hagenaars, S., Fears, S. C., Alonso-Lana, S., van Erp, T. G. M., Nickson, T., Chaim-Avancini, T. M., Meier, T. B., Elvsåshagen, T., Haukvik, U. K., Lee, W. H., Schene, A. H., Lloyd, A. J., Young, A. H., Nugent, A., Dale, A. M., Pfennig, A., McIntosh, A. M., Lafer, B., Baune, B. T., Ekman, C. J., Zarate, C. A., Bearden, C. E., Henry, C., Simhandl, C., McDonald, C., Bourne, C., Stein, D. J., Wolf, D. H., Cannon, D. M., Glahn, D. C., Veltman, D. J., Pomarol-Clotet, E., Vieta, E., Canales-Rodriguez, E. J., Nery, F. G., Duran, F. L. S., Busatto, G. F., Roberts, G., Pearlson, G. D., Goodwin, G. M., Kugel, H., Whalley, H. C., Ruhe, H. G., Soares, J. C., Fullerton, J. M., Rybakowski, J. K., Savitz, J., Chaim, K. T., Fatjó-Vilas, M., Soeiro-de-Souza, M. G., Boks, M. P., Zanetti, M. V., Otaduy, M. C. G., Schaufelberger, M. S., Alda, M., Ingvar, M., Phillips, M. L., Kempton, M. J., Bauer, M., Landén, M., Lawrence, N. S., van Haren, N. E. M., Horn, N. R., Freimer, N. B., Gruber, O., Schofield, P. R., Mitchell, P. B., Kahn, R. S., Lenroot, R., Machado-Vieira, R., Ophoff, R. A., Sarró, S., Frangou, S., Satterthwaite, T. D., Hajek, T., Dannlowski, U., Malt, U. F., Arolt, V., Gattaz, W. F., Drevets, W. C., Caseras, X., Agartz, I., Thompson, P. M., & Andreassen, O. A. (2018). Cortical abnormalities in bipolar disorder: An MRI analysis of 6503 individuals from the ENIGMA bipolar disorder working group. Molecular Psychiatry, 23(4), 932–942.Google Scholar
  34. Iscan, Z., Jin, T. B., Kendrick, A., Szeglin, B., Lu, H., Trivedi, M., Fava, M., McGrath, P. J., Weissman, M., Kurian, B. T., Adams, P., Weyandt, S., Toups, M., Carmody, T., McInnis, M., Cusin, C., Cooper, C., Oquendo, M. A., Parsey, R. V., & DeLorenzo, C. (2015). Test–retest reliability of FreeSurfer measurements within and between sites: Effects of visual approval process. Human Brain Mapping, 36(9), 3472–3485.Google Scholar
  35. Kempton, M. J., Geddes, J. R., Ettinger, U., Williams, S. C. R., & Grasby, P. M. (2008). Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Archives of General Psychiatry, 65(9), 1017–1032.Google Scholar
  36. Leng, Y., Liang, M. H., Ren, M., Marinova, Z., Leeds, P., & Chuang, D. M. (2008). Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: Roles of glycogen synthase kinase-3 inhibition. Journal of Neuroscience, 28(10), 2576–2588.Google Scholar
  37. Li, Y., Yuan, K., Cai, C., Feng, D., Yin, J., Bi, Y., Shi, S., Yu, D., Jin, C., von Deneen, K. M., Qin, W., & Tian, J. (2015). Reduced frontal cortical thickness and increased caudate volume within fronto-striatal circuits in young adult smokers. Drug and Alcohol Dependence, 151(2015), 211–219.Google Scholar
  38. Lopez-Jaramillo, C., Vargas, C., Diaz-Zuluaga, A. M., Palacio, J. D., Castrillon, G., Bearden, C., et al. (2017). Increased hippocampal, thalamus and amygdala volume in long-term lithium-treated bipolar I disorder patients compared with unmedicated patients and healthy subjects. Bipolar Disorders, 19(1), 41–49.Google Scholar
  39. Lyoo, I. K., Dager, S. R., Kim, J. E., Yoon, S. J., Friedman, S. D., Dunner, D. L., & Renshaw, P. F. (2010). Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: A longitudinal brain imaging study. Neuropsychopharmacology, 35(8), 1743–1750.Google Scholar
  40. McDonald, C. (2015). Brain structural effects of psychopharmacological treatment in bipolar disorder. Current Neuropharmacology, 13(4), 445–457.Google Scholar
  41. Moore, G. J., Cortese, B. M., Glitz, D. A., Zajacbenitez, C., Quiroz, J. A., Uhde, T. W., et al. (2009). A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. Journal of Clinical Psychiatry, 70(5), 699–705.Google Scholar
  42. Niu, M., Wang, Y., Jia, Y., Wang, J., Zhong, S., Lin, J., Sun, Y., Zhao, L., Liu, X., Huang, L., & Huang, R. (2017). Common and specific abnormalities in cortical thickness in patients with major depressive and bipolar disorders. EBioMedicine, 16, 162–171.Google Scholar
  43. Otten, M., & Meeter, M. (2015). Hippocampal structure and function in individuals with bipolar disorder: A systematic review. Journal of Affective Disorders, 174, 113–125.Google Scholar
  44. Phillips, M. L., & Swartz, H. A. (2014). A critical appraisal of neuroimaging studies of bipolar disorder: Toward a new conceptualization of underlying neural circuitry and a road map for future research. American Journal of Psychiatry, 171(8), 829–843.Google Scholar
  45. Pontious, A., Kowalczyk, T., Englund, C., & Hevner, R. F. (2008). Role of intermediate progenitor cells in cerebral cortex development. Developmental Neuroscience, 30(1–3), 24–32.Google Scholar
  46. Quiroz, J. A., Machadovieira, R., Zarate Jr., C. A., & Manji, H. K. (2010). Novel insights into lithium's mechanism of action: Neurotrophic and neuroprotective effects. Neuropsychobiology, 62(1), 50–60.Google Scholar
  47. Rakic, P. (1988). Specification of cerebral cortical areas. Science, 241(4862), 170–176.Google Scholar
  48. Rakic, P. (2007). The radial edifice of cortical architecture: From neuronal silhouettes to genetic engineering. Brain Research Reviews, 55(2), 204–219.Google Scholar
  49. Savitz, J., Nugent, A. C., Bogers, W., Liu, A., Sills, R., Luckenbaugh, D. A., Bain, E. E., Price, J. L., Zarate, C., Manji, H. K., Cannon, D. M., Marrett, S., Charney, D. S., & Drevets, W. C. (2010). Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: The impact of medication. NeuroImage, 49(4), 2966–2976.Google Scholar
  50. Selek, S., Nicoletti, M., Zunta-Soares, G. B., Hatch, J. P., Nery, F. G., Matsuo, K., Sanches, M., & Soares, J. C. (2013). A longitudinal study of fronto-limbic brain structures in patients with bipolar I disorder during lithium treatment. Journal of Affective Disorders, 150(2), 629–633.Google Scholar
  51. Townsend, J., & Altshuler, L. L. (2012). Emotion processing and regulation in bipolar disorder: A review. Bipolar Disorders, 14(4), 326–339.Google Scholar
  52. Vieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018). Bipolar disorders. Nature Reviews Disease Primers, 4, 18008.Google Scholar
  53. Wang, F., Kalmar, J. H., Womer, F. Y., Edmiston, E. E., Chepenik, L. G., Chen, R., Spencer, L., & Blumberg, H. P. (2011). Olfactocentric paralimbic cortex morphology in adolescents with bipolar disorder. Brain, 134(Pt 7), 2005–2012.Google Scholar
  54. Yamasaki, H., Labar, K. S., & Mccarthy, G. (2002). Dissociable prefrontal brain systems for attention and emotion. Proceedings of the National Academy of Sciences, 99(17), 11447–11451.Google Scholar
  55. Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978). A rating scale for mania: Reliability, validity and sensitivity. British Journal of Psychiatry, 133(5), 429–435.Google Scholar
  56. Yucel, K., Taylor, V. H., McKinnon, M. C., Macdonald, K., Alda, M., Young, L. T., et al. (2008). Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology, 33(2), 361–367.Google Scholar
  57. Zung, S., Souza-Duran, F. L., Soeiro-de-Souza, M. G., Uchida, R., Bottino, C. M., Busatto, G. F., & Vallada, H. (2016). The influence of lithium on hippocampal volume in elderly bipolar patients: A study using voxel-based morphometry. Translational Psychiatry, 6(6), e846.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Linling Li
    • 1
    • 2
    • 3
  • Erni Ji
    • 2
  • Xue Han
    • 4
    • 5
  • Fei Tang
    • 1
    • 3
  • Yuanhan Bai
    • 2
  • Daihui Peng
    • 6
  • Yiru Fang
    • 6
  • Shengli Zhang
    • 7
  • Zhiguo Zhang
    • 1
    • 3
    Email author
  • Haichen Yang
    • 2
    Email author
  1. 1.School of Biomedical Engineering, Health Science CenterShenzhen UniversityShenzhen 518060China
  2. 2.Department for Affective Disorders, Shenzhen Mental Health CentreShenzhen Key Lab for Psychological HealthcareShenzhen 518020China
  3. 3.Guangdong Provincial Key Laboratory of Biomedical Measurements and Ultrasound ImagingShenzhen UniversityShenzhen 518060China
  4. 4.Mental Health Institute of the Second Xiangya Hospital, National Technology Institute of Psychiatry, Key Laboratory of Psychiatry and Mental Health of Hunan ProvinceCentral South UniversityChangsha 410011China
  5. 5.Department of Mental HealthShenzhen Nanshan Center for Chronic Disease ControlShenzhen 518060China
  6. 6.Department for Mood Disorders, Shanghai Mental Health CenterShanghai Jiao Tong University School of MedicineShanghai 200030China
  7. 7.Department of Communication EngineeringShenzhen UniversityShenzhen 518060China

Personalised recommendations